ATE229970T1 - Verfahren zur herstellung von mometason furoat - Google Patents
Verfahren zur herstellung von mometason furoatInfo
- Publication number
- ATE229970T1 ATE229970T1 AT99308380T AT99308380T ATE229970T1 AT E229970 T1 ATE229970 T1 AT E229970T1 AT 99308380 T AT99308380 T AT 99308380T AT 99308380 T AT99308380 T AT 99308380T AT E229970 T1 ATE229970 T1 AT E229970T1
- Authority
- AT
- Austria
- Prior art keywords
- producing
- furoate
- mometason
- mometasone
- mometason furoate
- Prior art date
Links
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 abstract 1
- 229960001664 mometasone Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT102343A PT102343B (pt) | 1999-08-02 | 1999-08-02 | Processo para a preparacao de furoato mometasona |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE229970T1 true ATE229970T1 (de) | 2003-01-15 |
Family
ID=20085881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99308380T ATE229970T1 (de) | 1999-08-02 | 1999-10-25 | Verfahren zur herstellung von mometason furoat |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6177560B1 (de) |
| EP (1) | EP1074558B1 (de) |
| JP (1) | JP3746174B2 (de) |
| KR (1) | KR100640066B1 (de) |
| CN (1) | CN1149222C (de) |
| AT (1) | ATE229970T1 (de) |
| AU (1) | AU765592B2 (de) |
| CA (1) | CA2295455C (de) |
| DE (1) | DE69904585T2 (de) |
| DK (1) | DK1074558T3 (de) |
| ES (1) | ES2189354T3 (de) |
| HR (1) | HRP990341B1 (de) |
| HU (1) | HU227494B1 (de) |
| IL (1) | IL133752A (de) |
| NO (1) | NO321154B1 (de) |
| NZ (1) | NZ500555A (de) |
| PL (1) | PL191103B1 (de) |
| PT (1) | PT102343B (de) |
| RU (1) | RU2208616C2 (de) |
| SI (1) | SI1074558T1 (de) |
| UA (1) | UA60333C2 (de) |
| ZA (1) | ZA996758B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
| EP1790754A1 (de) * | 2005-11-24 | 2007-05-30 | Siemens Aktiengesellschaft | Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase |
| US8021742B2 (en) * | 2006-12-15 | 2011-09-20 | Siemens Energy, Inc. | Impact resistant thermal barrier coating system |
| SI3106149T1 (sl) * | 2009-05-29 | 2020-07-31 | Pearl Therapeutics, Inc. | Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| PT105139B (pt) * | 2010-06-01 | 2013-01-29 | Hovione Farmaciencia S A | Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos |
| HK1219059A1 (zh) | 2013-03-15 | 2017-03-24 | 珍珠治疗公司 | 用於微粒晶体材料的状态调节的方法和系统 |
| WO2014190204A1 (en) | 2013-05-22 | 2014-11-27 | Pearl Therapeutics, Inc. | Compositions, methods & systems for respiratory delivery of three or more active agents |
| CN105481933B (zh) * | 2015-12-25 | 2017-09-19 | 山东京卫制药有限公司 | 一种合成糠酸莫米松的方法 |
| CN105566437B (zh) * | 2015-12-30 | 2018-07-20 | 山东京卫制药有限公司 | 一种8dm衍生物及利用其合成糠酸莫米松的方法 |
| CN107266518B (zh) * | 2016-04-08 | 2021-03-30 | 天津金耀集团有限公司 | 一种糠酸莫米松晶型及其制备方法 |
| ES2981514T3 (es) | 2021-07-09 | 2024-10-09 | Astrazeneca Pharmaceuticals Lp | Composiciones, métodos y sistemas para el suministro de fármacos en aerosol |
| WO2023119093A1 (en) | 2021-12-20 | 2023-06-29 | Astrazeneca Ab | Compositions, methods and systems for aerosol drug delivery |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE8790T1 (de) * | 1981-02-02 | 1984-08-15 | Schering Corporation | Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. |
| ES2166549T3 (es) * | 1996-06-28 | 2002-04-16 | Schering Corp | Procedimiento de preparacion de 17-esteres de 9alfa,21-dihalo-pregnan-11beta,17alfadiol-20-onas. |
| US5886200A (en) * | 1996-07-01 | 1999-03-23 | Schering Corporation | Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones |
-
1999
- 1999-08-02 PT PT102343A patent/PT102343B/pt unknown
- 1999-08-02 NZ NZ500555A patent/NZ500555A/xx not_active IP Right Cessation
- 1999-10-21 HU HU9903747A patent/HU227494B1/hu unknown
- 1999-10-22 AU AU56024/99A patent/AU765592B2/en not_active Expired
- 1999-10-25 EP EP99308380A patent/EP1074558B1/de not_active Expired - Lifetime
- 1999-10-25 ES ES99308380T patent/ES2189354T3/es not_active Expired - Lifetime
- 1999-10-25 DK DK99308380T patent/DK1074558T3/da active
- 1999-10-25 SI SI9930173T patent/SI1074558T1/xx unknown
- 1999-10-25 DE DE69904585T patent/DE69904585T2/de not_active Expired - Lifetime
- 1999-10-25 AT AT99308380T patent/ATE229970T1/de active
- 1999-10-26 NO NO19995225A patent/NO321154B1/no not_active IP Right Cessation
- 1999-10-27 ZA ZA9906758A patent/ZA996758B/xx unknown
- 1999-11-03 KR KR1019990048285A patent/KR100640066B1/ko not_active Expired - Lifetime
- 1999-11-03 RU RU99123183/04A patent/RU2208616C2/ru active
- 1999-11-04 UA UA99116069A patent/UA60333C2/uk unknown
- 1999-11-05 JP JP31523699A patent/JP3746174B2/ja not_active Expired - Lifetime
- 1999-11-05 HR HR990341A patent/HRP990341B1/xx not_active IP Right Cessation
- 1999-11-05 PL PL336452A patent/PL191103B1/pl unknown
- 1999-11-26 CN CNB991243803A patent/CN1149222C/zh not_active Expired - Lifetime
- 1999-12-27 IL IL13375299A patent/IL133752A/en not_active IP Right Cessation
- 1999-12-29 US US09/476,004 patent/US6177560B1/en not_active Expired - Lifetime
-
2000
- 2000-01-14 CA CA002295455A patent/CA2295455C/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69907037D1 (de) | Verfahren zur herstellung von citalopram | |
| ATE213237T1 (de) | Verfahren zur herstellung von citalopram | |
| DE69332310D1 (de) | Verfahren zur herstellung von vorgefüllten, sterilen abgabevorrichtungen. | |
| EP0677100A4 (de) | Verfahren zur herstellung von neuroblasten. | |
| ATE324885T1 (de) | Verfahren zur herstellung von fenofibrathaltigen arzneizusammensetzungen mit erhöhter bioverfügbarkeit | |
| DE69719098D1 (de) | Verfahren zur herstellung von citalopram | |
| ATE229970T1 (de) | Verfahren zur herstellung von mometason furoat | |
| ATE222900T1 (de) | Verfahren zur herstellung von 5-cyanophthalid | |
| ATE281448T1 (de) | Verfahren zur herstellung von citalopram | |
| DE60005318D1 (de) | Verfahren zur herstellung von alpha-methylenlactonen | |
| ATE293595T1 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
| EP0968156A4 (de) | Gaserzeugende zusammensetzungen, verfahren zur herstellung und diese zusammensetzungen enthaltende vorrichtungen | |
| ATE262576T1 (de) | Verfahren zur herstellung von weichmittelzusammensetzungen | |
| ATE389645T1 (de) | Verfahren zur herstellung von citalopram | |
| DE69313297D1 (de) | Benzofuranone, benzodifurantrione und verfahren zur herstellung von benzodifurandionen | |
| ATE355268T1 (de) | Verfahren zur herstellung von citalopram | |
| DE59207782D1 (de) | Verfahren zur herstellung von 8,12-oxido-13,14,15,16-tetranorlabdan | |
| DE50006598D1 (de) | VERFAHREN ZUR HERSTELLUNG VON CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) | |
| DE59611076D1 (de) | Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen | |
| DE69000827D1 (de) | Verfahren zur herstellung von aminoxiden. | |
| ATE295349T1 (de) | Verfahren zur herstellung von ketiminen | |
| DE69708126D1 (de) | Verfahren zur herstellung von paclitaxel | |
| DE68914838D1 (de) | Verfahren zur herstellung von karbiden und siliciden auf mechanochemischem weg. | |
| DE60015944D1 (de) | Verfahren zur herstellung von alpha-methylenelactonen und alpha-substitutierten hydrocarbyliden-lactonen | |
| ATE258926T1 (de) | Verfahren zur herstellung von ranitidin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1074558 Country of ref document: EP |